Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
200.67
-4.43 (-2.16%)
Jun 13, 2025, 4:00 PM - Market closed

Danaher Market Cap

Danaher has a market cap or net worth of $143.61 billion as of June 13, 2025. Its market cap has decreased by -24.24% in one year.

Market Cap
143.61B
Enterprise Value
159.20B
1-Year Change
-24.24%
Ranking
Category
Stock Price
$200.67

Market Cap Chart

Since December 1, 1998, Danaher's market cap has increased from $6.13B to $143.61B, an increase of 2,244.56%. That is a compound annual growth rate of 12.62%.

History

DateMarket Cap% Change
Jun 13, 2025143.61B-13.38%
Dec 31, 2024165.80B-3.01%
Dec 29, 2023170.94B-11.53%
Dec 30, 2022193.22B-17.82%
Dec 31, 2021235.10B48.98%
Dec 31, 2020157.80B43.14%
Dec 31, 2019110.24B52.53%
Dec 31, 201872.28B11.94%
Dec 29, 201764.57B19.92%
Dec 30, 201653.84B-15.41%
Dec 31, 201563.65B5.68%
Dec 31, 201460.23B11.90%
Dec 31, 201353.82B39.00%
Dec 31, 201238.72B19.93%
Dec 30, 201132.29B4.66%
Dec 31, 201030.85B27.69%
Dec 31, 200924.16B33.51%
Dec 31, 200818.09B-33.56%
Dec 31, 200727.23B22.14%
Dec 29, 200622.30B29.74%
Dec 30, 200517.19B-3.00%
Dec 31, 200417.72B25.76%
Dec 31, 200314.09B40.70%
Dec 31, 200210.01B16.16%
Dec 31, 20018.62B-11.14%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 735.57B
Johnson & Johnson 377.99B
Novo Nordisk 355.28B
AbbVie 337.52B
UnitedHealth Group 284.42B
Abbott Laboratories 235.96B
Novartis AG 234.52B
AstraZeneca 231.58B
Market Cap Rankings